Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

Abstract

EGFR mutations in NSCLC cells are associated with sensitivity to gefitinib but not to cetuximab.